Minnesota-based Cardiovascular Systems (NSDQ:CSII) landed FDA clearance for a new size of its Diamondback 360 atherectomy system, used in treatment of peripheral artery disease.
Cardiovascular Systems Inc.
Cardiovascular Systems touts 1-year outcomes, cost savings for Diamondback 360
Minnesota-based Cardiovascular Systems (NSDQ:CSII) this week unveiled 1-year outcomes of a pivotal study of its Diamondback 360 device in treating coronary artery disease.
Cardiovascular Systems surges on Q2 results, outlook
Cardiovascular Systems (NSDQ:CSII) shares surged nearly 20% today on better-than-expected fiscal 2nd-quarter numbers and a 3rd-quarter outlook that came out well ahead of Wall Street’s forecast.
Cardiovascular Systems raises $84.5M through public offering
Minnesota medical device maker Cardiovascular Systems (NSDQ:CSII) announced that it raised $84.5 million through sales of 3 million shares of its common stock.
Cardiovascular Systems’ public offering could garner $70M
Cardiovascular Systems (NSDQ:CSII) announced this week an upcoming stock offering worth up to $70 million in net proceeds, according to an early estimate.
Cardiovascular Systems hits 52-week high on Q1 results
Cardiovascular Systems (NSDQ:CSII) shares posted a 52-week high just after noon today as investors reacted to strong fiscal 1st-quarter results.
Cardiovascular Systems jumps 18% on FDA approval
Wall Street rewards Cardiovascular Systems following strong 4th quarter
Covidien CEO Almeida wants more from emerging markets | Wall Street Beat
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.
Cardiovascular Systems launches post-market trial of PAD devices
Cardiovascular Systems (NSDQ:CSII) launched its Liberty 360° trial, a post-market evaluation of medical and economic outcomes for difficult-to-treat peripheral arterial disease cases.
Cardiovascular Systems prices $33M offering | Wall Street Beat
Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.